Zenotech Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 683231, "name": "Zenotech Lab.", "stock_name": "Zenotech Lab.", "full_name": "Zenotech Laboratories Ltd", "name_url": "stocks-analysis/zenotech-lab", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "46.40", "chg": 0.15, "chgp": "0.32%", "dir": 1, "prev_price": "46.25", "mcapval": "277.00 Cr", "mcap": "Micro Cap", "scripcode": 532039, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE486F01012", "curr_date": "Sep 01, 03:30 PM", "curr_time": "21:05 PM", "last_traded_at": "Sep 01, 03:30 PM IST", "bse_nse_vol": "2.4 k", "exc_status": "Active", "traded_date": "Sep 01, 2026", "traded_date_str": "2026 09 01", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Golden Cross Forms in Zenotech Laboratories Ltd — On a Day the Stock Gained 0.32%. What the Mixed Signals Mean", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4178205", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_goldencross_4178205.png", "date": "2026-09-01 18:00:27", "description": "The 50-day moving average has crossed above the 200-day moving average for Zenotech Laboratories Ltd, signalling a golden cross on 1 Sep 2026. Yet, the stock’s modest 0.32% gain on the day and a mixed set of technical indicators suggest the signal warrants a nuanced interpretation rather than straightforward optimism." }, { "title": "Zenotech Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4177613", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_mojoScore_4177613.png", "date": "2026-09-01 10:11:23", "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 July 2026, reflecting a change from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 01 September 2026, providing investors with the latest insights into the company's performance and outlook." }, { "title": "Zenotech Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4163773", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ZenotechLaborat_mojoScore_4163773.png", "date": "2026-08-21 10:10:59", "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Zenotech Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4145028", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ZenotechLaborat_mojoScore_4145028.png", "date": "2026-08-10 10:11:04", "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Zenotech Laboratories Gains 0.56%: 3 Key Factors Driving the Week’s Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-gains-056-3-key-factors-driving-the-weeks-move-4131784", "imagepath": "", "date": "2026-08-01 16:06:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens week with a 1.83% gain to Rs.45.10</p>\n <p><strong>28 Jul:</strong> Q1 FY27 results reveal deepening losses, stock falls 2.06%</p>\n <p><strong>30 Jul:</strong> Quality grade downgraded to average; Mojo rating cut to Strong Sell</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.44.54, up 0.20% on the day but below week open</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.44.29</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div..." }, { "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-4128047", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_mojoScore_4128047.png", "date": "2026-07-30 08:13:57", "description": "Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 29 July 2026, reflecting deteriorating fundamentals across quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s weakening operating performance, expensive valuation metrics, and persistent underperformance against benchmarks have prompted a reassessment of its outlook by analysts." }, { "title": "Zenotech Laboratories Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-quality-grade-downgrade-a-detailed-fundamental-analysis-4127724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_qualitydot_4127724.png", "date": "2026-07-30 08:00:06", "description": "Zenotech Laboratories Ltd has recently seen its quality grade downgraded from good to average, reflecting a shift in key business fundamentals. This article examines the underlying factors behind this change, analysing profitability metrics, debt levels, and operational efficiency to provide investors with a comprehensive view of the company’s evolving financial health." }, { "title": "Zenotech Laboratories Q1 FY27: Losses Deepen Amid Margin Collapse", "link": "https://www.marketsmojo.com/news/result-analysis/zenotech-laboratories-q1-fy27-losses-deepen-amid-margin-collapse-4124691", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_quaterlyResult_4124691.png", "date": "2026-07-28 20:01:32", "description": "Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company with a market capitalisation of ₹280.00 crores, reported a troubling quarter ended June 2026, posting a net loss of ₹0.46 crores compared to a profit of ₹0.99 crores in the corresponding quarter last year. The stock has reacted negatively to the results, trading at ₹44.17 as of July 28, 2026, down 2.06% on the day and reflecting broader concerns about the company's deteriorating operational performance and profitability metrics." }, { "title": "Zenotech Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-4117530", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_mojoScore_4117530.png", "date": "2026-07-23 10:11:14", "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook." } ], "total": 155, "sid": "683231", "stock_news_url": "https://www.marketsmojo.com/news/zenotech-laboratories-683231" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-Aug-2026", "details": "Newspaper publication informing about 37th Annual General Meeting & e-Voting.", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "28-Aug-2026", "details": "Annual Report 2025-26 and the Notice of 37th Annual General Meeting", "source": "BSE" }, { "caption": "Notice Of 37Th Annual General Meeting To Be Held On Friday September 25 2026 Along With Annual Report For The FY 2025-26.", "datetime": "28-Aug-2026", "details": "Notice of 37th Annual General Meeting along with Annual Report for the FY 2025-26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17", "dt": "2017-06-01", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

27 Jul: Stock opens week with a 1.83% gain to Rs.45.10

28 Jul: Q1 FY27 results reveal deepening losses, stock falls 2.06%

30 Jul: Quality grade downgraded to average; Mojo rating cut to Strong Sell

31 Jul: Week closes at Rs.44.54, up 0.20% on the day but below week open

Week Open

Rs.44.29

Week CloseRead full news article

Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals

2026-07-30 08:13:57

Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 29 July 2026, reflecting deteriorating fundamentals across quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s weakening operating performance, expensive valuation metrics, and persistent underperformance against benchmarks have prompted a reassessment of its outlook by analysts.

Read full news article

Zenotech Laboratories Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis

2026-07-30 08:00:06

Zenotech Laboratories Ltd has recently seen its quality grade downgraded from good to average, reflecting a shift in key business fundamentals. This article examines the underlying factors behind this change, analysing profitability metrics, debt levels, and operational efficiency to provide investors with a comprehensive view of the company’s evolving financial health.

Read full news article

Zenotech Laboratories Q1 FY27: Losses Deepen Amid Margin Collapse

2026-07-28 20:01:32

Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company with a market capitalisation of ₹280.00 crores, reported a troubling quarter ended June 2026, posting a net loss of ₹0.46 crores compared to a profit of ₹0.99 crores in the corresponding quarter last year. The stock has reacted negatively to the results, trading at ₹44.17 as of July 28, 2026, down 2.06% on the day and reflecting broader concerns about the company's deteriorating operational performance and profitability metrics.

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-07-23 10:11:14

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article